These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 1545130)

  • 21. Serologic responses of dogs naturally exposed to or vaccinated against Borrelia burgdorferi infection.
    Barthold SW; Levy SA; Fikrig E; Bockenstedt LK; Smith AL
    J Am Vet Med Assoc; 1995 Dec; 207(11):1435-40. PubMed ID: 7493871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attachment of Borrelia burgdorferi within Ixodes scapularis mediated by outer surface protein A.
    Pal U; de Silva AM; Montgomery RR; Fish D; Anguita J; Anderson JF; Lobet Y; Fikrig E
    J Clin Invest; 2000 Aug; 106(4):561-9. PubMed ID: 10953031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A fusion product of the complete Borrelia burgdorferi outer surface protein A (OspA) and the hepatitis B virus capsid protein is highly immunogenic and induces protective immunity similar to that seen with an effective lipidated OspA vaccine formula.
    Nassal M; Skamel C; Kratz PA; Wallich R; Stehle T; Simon MM
    Eur J Immunol; 2005 Feb; 35(2):655-65. PubMed ID: 15668917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi.
    Golde WT; Burkot TR; Piesman J; Dolan MC; Capiau C; Hauser P; Dequesne G; Lobet Y
    Vaccine; 1995 Apr; 13(5):435-41. PubMed ID: 7639011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral vaccination with an attenuated Salmonella typhimurium strain expressing Borrelia burgdorferi OspA prevents murine Lyme borreliosis.
    Dunne M; al-Ramadi BK; Barthold SW; Flavell RA; Fikrig E
    Infect Immun; 1995 Apr; 63(4):1611-4. PubMed ID: 7890431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abilities of OspA proteins from different seroprotective groups of Borrelia burgdorferi to protect hamsters from infection.
    Lovrich SD; Callister SM; DuChateau BK; Lim LC; Winfrey J; Day SP; Schell RF
    Infect Immun; 1995 Jun; 63(6):2113-9. PubMed ID: 7768589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic polymorphism of the gene encoding the outer surface protein A (OspA) of Borrelia burgdorferi.
    Zumstein G; Fuchs R; Hofmann A; Preac-Mursic V; Soutschek E; Wilske B
    Med Microbiol Immunol; 1992; 181(2):57-70. PubMed ID: 1406458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant outer surface protein a from Borrelia burgdorferi induces antibodies protective against spirochetal infection in mice.
    Simon MM; Schaible UE; Kramer MD; Eckerskorn C; Museteanu C; Müller-Hermelink HK; Wallich R
    J Infect Dis; 1991 Jul; 164(1):123-32. PubMed ID: 1829104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccination against Lyme disease caused by diverse Borrelia burgdorferi.
    Fikrig E; Telford SR; Wallich R; Chen M; Lobet Y; Matuschka FR; Kimsey RB; Kantor FS; Barthold SW; Spielman A; Flavell RA
    J Exp Med; 1995 Jan; 181(1):215-21. PubMed ID: 7807004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incomplete protection of hamsters vaccinated with unlipidated OspA from Borrelia burgdorferi infection is associated with low levels of antibody to an epitope defined by mAb LA-2.
    Johnson BJ; Sviat SL; Happ CM; Dunn JJ; Frantz JC; Mayer LW; Piesman J
    Vaccine; 1995 Aug; 13(12):1086-94. PubMed ID: 7491816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection of mice from Lyme borreliosis by oral vaccination with Escherichia coli expressing OspA.
    Fikrig E; Barthold SW; Kantor FS; Flavell RA
    J Infect Dis; 1991 Dec; 164(6):1224-7. PubMed ID: 1955724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant OspA protects dogs against infection and disease caused by Borrelia burgdorferi.
    Chang YF; Appel MJ; Jacobson RH; Shin SJ; Harpending P; Straubinger R; Patrican LA; Mohammed H; Summers BA
    Infect Immun; 1995 Sep; 63(9):3543-9. PubMed ID: 7642289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs.
    Scheckelhoff MR; Telford SR; Hu LT
    Vaccine; 2006 Mar; 24(11):1949-57. PubMed ID: 16300863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccination with meningococcal outer membrane vesicles carrying Borrelia OspA protects against experimental Lyme borreliosis.
    Klouwens MJ; Salverda MLM; Trentelman JJ; Ersoz JI; Wagemakers A; Gerritzen MJH; van der Ley PA; Hovius JW
    Vaccine; 2021 Apr; 39(18):2561-2567. PubMed ID: 33812741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance to tick-borne spirochete challenge induced by Borrelia burgdorferi strains that differ in expression of outer surface proteins.
    Kurtti TJ; Munderloh UG; Hughes CA; Engstrom SM; Johnson RC
    Infect Immun; 1996 Oct; 64(10):4148-53. PubMed ID: 8926082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of protection in rabbits against host-adapted and cultivated Borrelia burgdorferi following infection-derived immunity or immunization with outer membrane vesicles or outer surface protein A.
    Shang ES; Champion CI; Wu XY; Skare JT; Blanco DR; Miller JN; Lovett MA
    Infect Immun; 2000 Jul; 68(7):4189-99. PubMed ID: 10858236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Humoral immunity to Borrelia burgdorferi N40 decorin binding proteins during infection of laboratory mice.
    Feng S; Hodzic E; Stevenson B; Barthold SW
    Infect Immun; 1998 Jun; 66(6):2827-35. PubMed ID: 9596756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunization with a polyvalent OspA vaccine protects mice against Ixodes ricinus tick bites infected by Borrelia burgdorferi ss, Borrelia garinii and Borrelia afzelii.
    Gern L; Hu CM; Voet P; Hauser P; Lobet Y
    Vaccine; 1997 Oct; 15(14):1551-7. PubMed ID: 9330467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid outer-surface protein C DNA tattoo vaccination protects against Borrelia afzelii infection.
    Wagemakers A; Mason LM; Oei A; de Wever B; van der Poll T; Bins AD; Hovius JW
    Gene Ther; 2014 Dec; 21(12):1051-7. PubMed ID: 25273355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and development of a novel vaccine for protection against Lyme borreliosis.
    Comstedt P; Hanner M; Schüler W; Meinke A; Lundberg U
    PLoS One; 2014; 9(11):e113294. PubMed ID: 25409015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.